ATE480557T1 - Inducer von atopischer dermatitis - Google Patents

Inducer von atopischer dermatitis

Info

Publication number
ATE480557T1
ATE480557T1 AT04747610T AT04747610T ATE480557T1 AT E480557 T1 ATE480557 T1 AT E480557T1 AT 04747610 T AT04747610 T AT 04747610T AT 04747610 T AT04747610 T AT 04747610T AT E480557 T1 ATE480557 T1 AT E480557T1
Authority
AT
Austria
Prior art keywords
atopic dermatitis
inducer
human
supernatant
filtrate
Prior art date
Application number
AT04747610T
Other languages
English (en)
Inventor
Michihiro Hide
Toshihiko Tanaka
Akio Tanaka
Kaori Ishii
Hidenori Suzuki
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi & Co filed Critical Shionogi & Co
Application granted granted Critical
Publication of ATE480557T1 publication Critical patent/ATE480557T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4283—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig
    • C07K16/4291—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig against IgE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT04747610T 2003-07-09 2004-07-09 Inducer von atopischer dermatitis ATE480557T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003194642 2003-07-09
PCT/JP2004/010144 WO2005005474A1 (ja) 2003-07-09 2004-07-09 アトピー性皮膚炎誘引物質

Publications (1)

Publication Number Publication Date
ATE480557T1 true ATE480557T1 (de) 2010-09-15

Family

ID=34055695

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04747610T ATE480557T1 (de) 2003-07-09 2004-07-09 Inducer von atopischer dermatitis

Country Status (8)

Country Link
US (2) US20060134706A1 (de)
EP (1) EP1655307B1 (de)
JP (1) JP3983260B2 (de)
KR (1) KR101156523B1 (de)
AT (1) ATE480557T1 (de)
CA (1) CA2536354C (de)
DE (1) DE602004029058D1 (de)
WO (1) WO2005005474A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5924752B2 (ja) * 2008-05-02 2016-05-25 国立大学法人広島大学 抗汗抗原モノクローナル抗体
US8945895B2 (en) 2009-07-31 2015-02-03 Baxter International Inc. Methods of purifying recombinant ADAMTS13 and other proteins and compositions thereof
JP5786020B2 (ja) 2010-04-16 2015-09-30 アボットジャパン株式会社 関節リウマチを診断する方法および試薬
WO2014003008A1 (ja) 2012-06-28 2014-01-03 国立大学法人広島大学 ヒト汗中に含まれる新規ヒスタミン遊離物質
EP2886554A4 (de) * 2012-08-17 2016-09-07 Univ Hiroshima An schweissallergie-antigenprotein bindender monoklonaler ige-antikörper
JP6628946B2 (ja) * 2017-12-26 2020-01-15 大太朗 福岡 増毛、頭皮若しくは皮膚の改質、創傷治癒、骨形成促進、または毛髪の改質に用いるための医薬組成物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5834192A (en) * 1996-04-05 1998-11-10 Incyte Pharmaceuticals, Inc. Human cachexia associated protein
AU4199597A (en) * 1996-09-09 1998-04-02 Novo Nordisk A/S A cdna and peptide with relation to cancer and weight loss
DE10129983A1 (de) * 2001-06-13 2003-01-30 Univ Eberhard Karls Antimikrobiell wirkendes Peptid
JP4399260B2 (ja) * 2001-08-24 2010-01-13 ニューレン ファーマシューティカルズ リミテッド 神経再生ペプチドおよび脳損傷治療におけるその使用方法
WO2003084991A1 (fr) 2002-04-08 2003-10-16 Japan Science And Technology Agency Proteines inductrices de dermatites atopiques
AU2003279084A1 (en) * 2002-09-25 2004-04-19 Genentech, Inc. Novel compositions and methods for the treatment of psoriasis
JP2004361227A (ja) * 2003-06-04 2004-12-24 Tohoku Univ アミロイドβ結合蛋白質の同定方法

Also Published As

Publication number Publication date
CA2536354C (en) 2013-08-13
EP1655307B1 (de) 2010-09-08
JP3983260B2 (ja) 2007-09-26
WO2005005474A1 (ja) 2005-01-20
JPWO2005005474A1 (ja) 2010-03-25
US20100080854A1 (en) 2010-04-01
US20060134706A1 (en) 2006-06-22
CA2536354A1 (en) 2005-01-20
KR20060126419A (ko) 2006-12-07
EP1655307A4 (de) 2006-07-26
EP1655307A1 (de) 2006-05-10
KR101156523B1 (ko) 2012-06-20
US8129507B2 (en) 2012-03-06
DE602004029058D1 (de) 2010-10-21

Similar Documents

Publication Publication Date Title
EA200700335A1 (ru) Обработка воды с использованием фильтрации, улучшенной дендримерами
PT1639011E (pt) Anticorpos (dab) de domínio único peguilados
WO2004091485A3 (en) Aminoquinoline compounds
ATE297755T1 (de) Verwendung von lactoferrin in der behandlung von beschwerden, die von allergenen verursacht sind
ATE512986T1 (de) Antikörper gegen clostridium difficile-toxine und ihre verwendung
ATE495715T1 (de) Filtermembran mit vergrösserter oberfläche
WO2003100033A3 (en) ANTI-αvβ6 ANTIBODIES
DE60329839D1 (de) Behandlung und verhütung von gewebeschäden, die mit erhöhter produktion von c-reactivem protein verbunden sind
FI971756A0 (fi) CD23:een sitoutuvia aineita
ATE480557T1 (de) Inducer von atopischer dermatitis
EA200500863A1 (ru) Способ обработки катализаторной мелочи и её устранение
ATE437849T1 (de) Verfahren zur reinigung von dianhydriden
DE60125563D1 (de) Verfahren zur verwendung eines humanen il-17 verwandten polypeptids zur behandlung von krankheiten
DE60027481D1 (de) Zusammensetzung zur Behandlung von chronischer venöser Insuffizienz mit einem Extrakt aus Blättern von roten Weinreben
DE59610319D1 (de) Entfernen von Viren durch Ultrafiltration aus Proteinlösungen
EA199800685A1 (ru) Разделение компонентов плазмы крови с помощью фильтрующих средств на основе целлюлозы
ID25978A (id) Antibodi anti-fas
DE69813868D1 (de) Verwendung von zytokinen und mitogenen für inhibierung von pathologischen immunantworten
DE69615843D1 (de) Il-8 antagonisten zur behandlung von asthma
ATE191568T1 (de) Spezifische bindungssubstanzen für antikörper und deren verwendung für immunoassays oder vakzine
NZ332648A (en) Vasoactive amine binding proteins (VABP) and vasoactive amine binding molecules (VABM)
EP0969095A3 (de) (S)-Hydroxynitrillyasen mit verbesserter Substanzakzeptanz und deren Verwendung
DE50212790D1 (de) Verfahren zum nachweis von blutzell-antigenen und gegen diese gerichtete antikörper
BR9916057B1 (pt) processo para remoção de água de lìquidos orgánicos usando peneiras moleculares de baixa acidez.
DE69629573D1 (de) Verfahren zur bestimmung von stickstoffoxyd

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties